928653-73-0

Basic information

• Product Name: 5-BROMO-2-CHLORO-3-IODO-PYRIDINE
• Synonyms: 2-chloro -5-broMo-3-iodopyridine
• CAS NO: 928653-73-0
• Molecular Formula: C₅H₂BrClIN
• Molecular Weight: 318.34
• Mol File: 928653-73-0.mol

Chemical Properties

• Boiling Point: 301°C at 760 mmHg
• Flash Point: 135.9°C
• Appearance: /
• Density: 2.395g/cm³
• Vapor Pressure: 0.00193mmHg at 25°C
• Refractive Index: 1.673
• Storage Temp.: under inert gas (nitrogen or Argon) at 2–8 °C
• PKA: -3.09±0.10(Predicted)
• CAS DataBase Reference: 5-BROMO-2-CHLORO-3-IODO-PYRIDINE(CAS DataBase Reference)
• NIST Chemistry Reference: 5-BROMO-2-CHLORO-3-IODO-PYRIDINE(928653-73-0)
• EPA Substance Registry System: 5-BROMO-2-CHLORO-3-IODO-PYRIDINE(928653-73-0)

Safety Data

• Hazard Codes: Xi
• Statements: 36
• Safety Statements: 26
• RIDADR: 2811
• WGK Germany: 3
• HazardClass: IRRITANT
• PackingGroup: Ⅲ
• Hazardous Substances Data: 928653-73-0(Hazardous Substances Data)

Usage

Uses

Used in Organic Synthesis:
5-Bromo-2-chloro-3-iodo-pyridine is used as a versatile building block for the synthesis of more complex organic compounds. Its unique combination of halogen atoms allows for a wide range of chemical reactions and transformations, making it a valuable intermediate in the preparation of various organic molecules.
Used in Chemical Reactions:
5-Bromo-2-chloro-3-iodo-pyridine is used as a reagent in different chemical reactions. Its high reactivity and the presence of multiple halogens enable it to participate in various reaction pathways, such as substitution, elimination, and coupling reactions, contributing to the formation of new compounds with desired properties.
Used in Pharmaceutical Industry:
5-Bromo-2-chloro-3-iodo-pyridine is used as a key intermediate in the synthesis of pharmaceutical compounds. Its unique structural features and reactivity make it suitable for the development of new drugs with potential therapeutic applications.
Used in Material Science:
5-Bromo-2-chloro-3-iodo-pyridine is used in the development of new materials with specific properties. Its reactivity and the presence of multiple halogens allow for the creation of novel materials with tailored characteristics, such as improved stability, enhanced reactivity, or specific optical, electronic, or magnetic properties.
Used in Research and Development:
5-Bromo-2-chloro-3-iodo-pyridine is used as a research compound in academic and industrial laboratories. Its unique properties and reactivity make it an interesting subject for studying various aspects of chemistry, such as reaction mechanisms, structure-property relationships, and the development of new synthetic methods.

InChI:InChI=1/C5H2BrClIN/c6-3-1-4(8)5(7)9-2-3/h1-2H

Upstream product

• 381233-75-6 5-bromo-2-hydroxy-3-iodopyridine 
• 13466-38-1 5-bromopyridin-2-ol 

Downstream Products

• 1349723-06-3 5-bromo-3-[1-(2-chloro-3-fluoro-6-methoxyphenyl)ethyl]-1H-pyrazolo[3,4-b]pyridine 
• 1349723-08-5 1-(5-bromo-2-chloropyridin-3-yl)-2-(2-chloro-3-fluoro-6-methoxyphenyl)-propan-1-one 
• 1349723-10-9 1-(5-bromo-2-chloropyridin-3-yl)-2-(2-chloro-3-fluoro-6-methoxyphenyl)propan-1-ol 

Relevant articles and documents

BCL-2 FAMILY PROTEINS MODULATING COMPOUNDS FOR CANCER TREATMENT

The present invention relates to compounds, compositions and methods for treating cancers and disorders of cell proliferation and more particularly, methods of making and using compounds that modulate at least one of the proteins chosen from Bcl-2, Mcl-1,

Br vs. TsO Chemoselective Suzuki–Miyaura Cross-Coupling Reaction on Nicotinaldehyde Moiety for the Preparation of 2,3,5-Trisubstituted Pyridines

Br vs. TsO chemoselective pallado-catalyzed Suzuki–Miyaura reaction has been developed from the 5-bromo-2-tosyloxynicotinaldehyde for the preparation of polysubstituted pyridines. This methodology has been applied for the preparation of a terpyridine alde

First evidence that oligopyridines, α-helix foldamers, inhibit Mcl-1 and sensitize ovarian carcinoma cells to Bcl-xL-targeting strategies

Apoptosis control defects such as the deregulation of Bcl-2 family member expression are frequently involved in chemoresistance. In ovarian carcinoma, we previously demonstrated that Bcl-xL and Mcl-1 cooperate to protect cancer cells against ap

MCL-1 MODULATING COMPOUNDS FOR CANCER TREATMENT

The invention relates to compounds of formula (I), and to their therapeutic use in the treatment of cancer : Wherein Y1, Y2, Ar1, Ar2, R1, R2, i, j, k, 1 are as defined in claim 1